Cellino Biotech has received $25 million in funding from the Advanced Research Projects Agency for Health (ARPA-H), an agency of the U.S. Department of Health and Human Services. The funding will ...
The promise of tumor-infiltrating lymphocytes (TIL) therapy is expanding beyond melanoma to a wide range of solid tumors, but the path to clinical success remains complex. Variability in tumor tissue ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback